Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

Henckaerts, Liesbet; Pierik, Marie; Joossens, Marie; Ferrante, Marc; Rutgeerts, Paul; Vermeire, Séverine
November 2007
Gut;Nov2007, Vol. 56 Issue 11, p1536
Academic Journal
Background and aims: A number of antibodies against microbial epitopes or self-antigens have been associated with Crohn's disease. The development of antibodies reflects a loss of tolerance to intestinal bacteria that underlies Crohn's disease, resulting in an exaggerated adaptive immune response to these bacteria. It was hypothesised that the development of antimicrobial antibodies is influenced by the presence of genetic variants in pattern recognition receptor genes. The aim of this study was therefore to investigate the influence of mutations in these innate immune receptor genes (nucleotide oligomerisation domain (NOD) 2/caspase recruitment domain (CARD) 15, NOD1 /CARD4, TUCAN/CARDINAL/CARD8, Toll-like receptor (TLR) 4, TLR2, TLR1 and TLR6) on the development of antimicrobial and antiglycan antibodies in inflammatory bowel disease (IBD). Materials and methods: A cohort of 1163 unrelated patients with IBD (874 Crohn's disease, 259 ulcerative colitis, 30 indeterminate colitis) and 312 controls were analysed for anti-Saccharomyces cerevisiae antibodies (gASCA) IgG, anti-laminaribioside antibodies (ALCA) IgG, anti-chitobioside antibodies (ACCA) IgA, anti-mannobioside antibodies (AMCA) IgG and outer membrane porin (Omp) IgA and were genotyped for variants in NOD2/CARD15, TUCAN/CARDINAL/CARD8, NOD1/CARD4, TLR4, TLR1, TLR2 and TLR6. Results: When compared with Crohn's disease patients without CARD 15 mutations, the presence of at least one CARD15 variant in Crohn's disease patients more frequently led to gASCA positivity (66.1% versus 51.5%, p < 0.0001) and ALCA positivity (43.3% versus 34.9%, p = 0.018) and higher gASCA titers (85.7 versus 51.8 ELISA units, p < 0.0001), independent of ileal involvement. A gene dosage effect, with increasing gASCA and ALCA positivity for patients carrying none, one and two CARD15 variants, respectively, was seen for both markers. Similarly, Crohn's disease patients carrying NOD1/CARD4 indel had a higher prevalence of gASCA antibodies than wild-type patients (63.8% versus 55.2%, p = 0.014), also with a gene dosage effect. An opposite effect was observed for the TLR4 D299G and TLR2 P631H variants, with a lower prevalence of ACCA antibodies (23.4% versus 35%, p = 0.013) and Omp antibodies (20.5% versus 34.6%, p = 0.009), respectively. Conclusion: Variants in innate immune receptor genes were found to influence antibody formation against microbial epitopes. In this respect, it is intriguing that an opposite effect of CARD15 and TLR4 variants was observed. These findings may contribute to an understanding of the aetiology of the seroreactivity observed in IBD.


Related Articles

  • Comparison of epitope specificity of anti-heat shock protein 60/65 IgG type antibodies in the sera of healthy subjects, patients with coronary heart disease and inflammatory bowel disease. Füst, George; Uray, Katalin; Bene, László; Hudecz, Ferenc; Karádi, István; Prohászka, Zoltán // Cell Stress & Chaperones;Summer2012, Vol. 17 Issue 2, p215 

    Previously, we reported on the presence of antibodies to linear epitopes of human and mycobacterial 60 kD heat shock proteins (HSP) in the sera of healthy blood donors. Since many recent findings indicate that the levels of these antibodies may be altered in coronary heart disease (CHD) and also...

  • Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Suwannalai, Parawee; Trouw, Leendert; Toes, Rene; Huizinga, Tom // Modern Rheumatology;Feb2012, Vol. 22 Issue 1, p15 

    Autoantibodies with the highest specificity for rheumatoid arthritis (RA) are the antibodies directed to citrulline-containing epitopes, so-called anti-citrullinated peptide/protein antibodies (ACPA). During the past decade it became clear that the presence of these antibodies was highly...

  • Intravenous Immunoglobulin Therapy for Active, Extensive, and Medically Refractory Idiopathic Ulcerative or Crohn's Colitis. Levine, Douglas S.; Fischer, Susanna H.; Christie, Dennis L.; Haggitt, Rodger C.; Ochs, Hans D. // American Journal of Gastroenterology;Jan1992, Vol. 87 Issue 1, p91 

    To determine whether intravenous immunogtobulin produces demonstrable clinical improvement in patients with refractory idiopathic inflammatory bowel disease, a pilot, open-label, nonrandomized, safety and therapeutic efficacy study was carried out at a tertiary care referral medical center....

  • Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease. Balzola, Federico; Bernstein, Charles; Ho, Gwo-Tzer; Russell, Richard K. // Inflammatory Bowel Disease Monitor;2011, Vol. 12 Issue 2, p66 

    The article presents a study on acute severe reactions of inflammatory bowel disease (IBD) patients to infliximab. The role of anti-infliximab antibodies and other possible risk factors, such as episodic treatment and age, for acute severe reactions were examined. The study shows that the...

  • Inflammatory Bowel Disease.  // American Journal of Gastroenterology;Oct2013 Supplement, Vol. 108, pS500 

    The article presents abstracts on inflammatory bowel disease which include a study on effect of age on Crohn's disease (CD) and ulcerative colitis (UC), a research on patients' knowledge of inflammatory bowel disease medication side effects, and use of Vedolizumab antibody for the treatment of UC.

  • Prevalence of serum celiac antibody in patients with IBD in Japan. Watanabe, Chikako; Komoto, Shunsuke; Hokari, Ryota; Kurihara, Chie; Okada, Yoshikiyo; Hozumi, Hideaki; Higashiyama, Masaaki; Sakuraba, Atsushi; Tomita, Kengo; Tsuzuki, Yoshikazu; Kawaguchi, Atsushi; Nagao, Shigeaki; Ogata, Sho; Miura, Soichiro // Journal of Gastroenterology;May2014, Vol. 49 Issue 5, p825 

    Background: Although the incidence of inflammatory bowel diseases (IBD) in Japan has increased, the prevalence of celiac disease is considered very low with the lowest genetic disposition. IBD is reported as the most common comorbidity because of the high positive rate of serological celiac...

  • Activation of the NFκB Pathway Enhances AhR Expression in Intestinal Caco-2 Cells. Champion, S.; Sauzet, C.; Bremond, P.; Benbrahim, K.; Abraldes, J.; Seree, E.; Barra, Y.; Villard, P. H. // ISRN Toxicology;2013, p1 

    Recent data suggest that apart from its well-known role in the regulation of xenobiotic metabolizing enzymes, AhR is also involved in inflammation. However, the influence of inflammation on AhR expression remains unknown. Here, we demonstrated that proinflammatory conditions induced by either...

  • Circulating Antibody and Memory B-Cell Responses to C. difficile Toxins A and B in Patients with C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic Fibrosis. Monaghan, Tanya M.; Robins, Adrian; Knox, Alan; Sewell, Herbert F.; Mahida, Yashwant R. // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    C. difficile infection (CDI) is rarely reported in cystic fibrosis (CF) patients despite frequent hospitalisations and antibiotic usage. Conversely, the prevalence of CDI in inflammatory bowel disease (IBD) has received increased attention. We investigated components of the IgG-specific humoral...

  • Characterization of Changes in Serum Anti-Glycan Antibodies in Crohn's Disease - a Longitudinal Analysis. Rieder, Florian; Lopez, Rocio; Franke, Andre; Wolf, Alexandra; Schleder, Stephan; Dirmeier, Andrea; Schirbel, Anja; Rosenstiel, Philip; Dotan, Nir; Schreiber, Stefan; Rogler, Gerhard; Klebl, Frank // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Introduction: Anti-glycan antibodies are a promising tool for differential diagnosis and disease stratification of patients with Crohn's disease (CD). We longitudinally assessed level and status changes of anti-glycan antibodies over time in individual CD patients as well as determinants of this...


Read the Article


Sign out of this library

Other Topics